Cognitive‐nigrostriatal relationships in de novo, drug‐naïve Parkinson's disease patients: A [I‐123]FP‐CIT SPECT study

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Movement Disorders

• Publication date

  2010-01-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/mds.22899PMID 20058228
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy.

  2009cited by this paper
• Cognitive impairment in incident, untreated Parkinson disease

  2009cited by this paper
• Striatal dopamine transporter abnormalities in patients with essential tremor

  2008cited by this paper
• Neuropsychological Characteristics of Dementia with Lewy Bodies and Parkinson’s Disease with Dementia: Differentiation, Early Detection, and Implications for “Mild Cognitive Impairment” and Biomarkers

  2008cited by this paper
• Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA.

  2008cited by this paper
• Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia.

  2008cited by this paper
• Cognitive deficits and striato-frontal dopamine release in Parkinson's disease.

  2008cited by this paper
• The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation

  2007cited by this paper
• Cognitive dysfunction and dementia in Parkinson disease

  2007cited by this paper
• Molecular imaging of the dopaminergic system and its association with human cognitive function.

  2006influential reference
• Challenging the Serotonergic System in Parkinson Disease Patients: Effects on Cognition, Mood, and Motor Performance

  2006influential reference
• Corsi Block-Tapping Task Performance as a Function of Path Configuration

  2005cited by this paper
• Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies

  2004cited by this paper
• Cognitive dysfunction and dementia in Parkinson’s disease

  2004cited by this paper
• What causes mental dysfunction in Parkinson's disease?

  2003cited by this paper
• Regional cerebral blood flow in Parkinson's disease with and without dementia

  2003cited by this paper
• Dopamine and cognitive function

  2003cited by this paper
• Occipital hypoperfusion in Parkinson’s disease without dementia: correlation to impaired cortical visual processing

  2003cited by this paper
• Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study.

  2003cited by this paper
• Variability of Trail Making Test, Symbol Digit Test and Line Trait Test in normal people. A normative study taking into account age-dependent decline and sociobiological variables

  2002cited by this paper
• Cognitive Deficits and Striatal Dopaminergic Denervation in Parkinson's Disease: A Single Photon Emission Computed Tomography Study Using 123Iodine-&bgr;-CIT in Patients ON and OFF Levodopa

  2002cited by this paper
• European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligands.

  2002cited by this paper
• Clinical practice. Essential tremor.

  2001cited by this paper
• Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus.

  2001cited by this paper
• Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease.

  2000cited by this paper
• Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study.

  2000cited by this paper
• Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study.

  2000cited by this paper
• Striatal [123I]β-CIT SPECT and prefrontal cognitive functions in Parkinson's disease

  2000cited by this paper
• Impaired somatosensory discrimination of shape in Parkinson's disease: Association with caudate nucleus dopaminergic function

  1999cited by this paper
• Diagnostic criteria for Parkinson disease.

  1999cited by this paper
• Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease.

  1999cited by this paper
• A simple model for the efficient correction of collimator blur in 3D SPECT imaging

  1999cited by this paper
• Neuropsychological prediction of dementia in Parkinson’s disease

  1998cited by this paper
• A normative study on visual reaction times and two Stroop colour-word tests

  1998cited by this paper
• Neuropsychological prediction of dementia in Parkinson’s disease

  1998cited by this paper
• Functional effects of striatal dysfunction in Parkinson disease.

  1997cited by this paper
• The Mental Deterioration Battery: Normative Data, Diagnostic Reliability and Qualitative Analyses of Cognitive Impairment

  1996cited by this paper
• In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease

  1996cited by this paper
• The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery.

  1996cited by this paper
• Accelerated image reconstruction using ordered subsets of projection data

  1994cited by this paper
• Discordant twins with Parkinson's disease: Positron emission tomography and early signs of impaired cognitive circuits

  1994cited by this paper
• Clock Completion: An Objective Screening Test for Dementia

  1993cited by this paper
• Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra

  1989cited by this paper
• Distinguishing normal and demented elderly with the selective reminding test.

  1989cited by this paper
• Raven's coloured progressive matrices: normative values on 305 adult normal controls.

  1987cited by this paper
• Verbal and spatial immediate memory span: Normative data from 1355 adults and 1112 children

  1987cited by this paper
• Tre test clinici di ricerca e produzione lessicale

  1986cited by this paper
• Tre test di produzione e ricerca lessicale

  1986cited by this paper
• Progress in development of the index of ADL.

  1970cited by this paper
• Assessment of older people: self-maintaining and instrumental activities of daily living.

  1969cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Review Dementia Associated with Parkinson's Disease Panel 1. Risk Factors for Dementia in Patients with Pd

  year unknowncited by this paper

• Visuospatial dysfunction indicates an increased risk of rapid dementia conversion in Parkinson's disease

  2026cites this paper
• Interplay of age-sensitive cortical vulnerability and dopaminergic degeneration in clinical manifestations of Parkinson's disease.

  2026cites this paper
• The Caudate Nucleus Exhibits Distinct Pathology and Cell Type-Specific Responses Across Alzheimer’s Disease

  2026cites this paper
• Relationship between striatal dopaminergic depletion and cognitive milestone in Parkinson's disease: A comprehensive analysis of striatal subregions, laterality, and nonlinear relationships

  2025influential citation
• EEG alpha peak frequency: cognitive impairment severity marker in isolated REM sleep behavior disorder

  2025influential citation
• Nuclear Medicine Imaging Biomarkers in Parkinson’s Disease: Past, Present, and Future Directions

  2025cites this paper
• Association Between Dopamine Transporter Activity in the Striatum on 18F-FP-CIT PET and Overall Survival of Patients With Parkinsonism.

  2025cites this paper
• PINK1 knockout rats show premotor cognitive deficits measured through a complex maze

  2024cites this paper
• Radionuclide Imaging of the Neuroanatomical and Neurochemical Substrate of Cognitive Decline in Parkinson’s Disease

  2024cites this paper
• Selective effects of dopaminergic and noradrenergic degeneration on cognition in Parkinson's disease

  2024cites this paper
• Exploring the Distinct Effect of Age at Onset and Caudate Denervation on Cognitive Deficits in Early Parkinson’s Disease

  2024cites this paper
• Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson Disease–Related Cognitive Impairment

  2024cites this paper
• Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy

  2024cites this paper
• Altered Brain Dynamics in idiopathic REM sleep behavior disorder: Implications for a continuum from prodromal to overt alpha-synucleinopathies

  2023cites this paper
• Right posterior hypometabolism in Pisa syndrome of Parkinson's disease: A key to explain body schema perception deficit?

  2023cites this paper
• Impact of the Dopamine System on Long‐Term Cognitive Impairment in Parkinson Disease: An Exploratory Study

  2023cites this paper
• Striatal Dopaminergic Depletion Pattern Reflects Pathological Brain Perfusion Changes in Lewy Body Diseases

  2022cites this paper
• Associations between white matter hyperintensities, striatal dopamine loss, and cognition in drug-naïve Parkinson's disease.

  2022cites this paper
• Validation of dynamic [18F]FE-PE2I PET for estimation of relative regional cerebral blood flow: a comparison with [15O]H2O PET

  2022cites this paper
• Effects of monotherapy with a monoamine oxidase B inhibitor on motor symptoms in Parkinson’s disease are dependent on frontal function

  2022cites this paper
• Defining the unknowns for cell therapies in Parkinson's disease

  2022cites this paper
• Pearls & Oy-sters: A Case Report of Holmes Tremor Due to Nigrostriatal Dopamine Disruption That Responded to Dopamine Replacement Therapy

  2022cites this paper
• Can cell and gene therapies improve cognitive symptoms in Parkinson's disease?

  2022cites this paper
• Striatal dopamine correlates to memory and attention in Parkinson's disease.

  2021cites this paper
• Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients

  2021cites this paper
• Imaging Cognitive Impairment and Impulse Control Disorders in Parkinson's Disease

  2021cites this paper
• Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review

  2021cites this paper
• Phase and amplitude electroencephalography correlations change with disease progression in people with idiopathic rapid eye-movement sleep behavior disorder

  2021cites this paper
• Imaging the Pathophysiology of Essential Tremor—A Systematic Review

  2021cites this paper
• Abnormally reduced frontal cortex activity during Trail-Making-Test in prodromal parkinson's disease-a fNIRS study.

  2021cites this paper
• Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson’s disease

  2021cites this paper
• Sleep Disorders and Cognitive Dysfunctions in Parkinson’s Disease: A Meta-Analytic Study

  2021influential citation
• Phase and amplitude correlations change with disease progression in idiopathic Rapid eye-movement sleep behavior disorder patients

  2021cites this paper
• Dopaminergic and Metabolic Correlations With Cognitive Domains in Non-demented Parkinson’s Disease

  2021cites this paper
• Imaging Mild Cognitive Impairment and Dementia in Parkinson's Disease

  2020cites this paper
• Brain iron deposition is linked with cognitive severity in Parkinson’s disease

  2020cites this paper
• Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease.

  2020cites this paper
• The fate of patients with REM sleep behavior disorder and mild cognitive impairment.

  2020cites this paper
• Processing speed is related to striatal dopamine transporter availability in Parkinson's disease

  2020influential citation
• Magnetic Susceptibility Associates With Dopaminergic Deficits and Cognition in Parkinson's Disease

  2020cites this paper
• Positron emission computed tomography/single photon emission computed tomography in Parkinson disease

  2020cites this paper
• Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.

  2020cites this paper
• Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools

  2020cites this paper
• Striatal dopamine transporters and cognitive function in Parkinson’s disease

  2020cites this paper
• Patterns of striatal dopamine depletion in early Parkinson disease

  2020cites this paper
• Functional neuroimaging evidence supporting the dual syndrome hypothesis of cognitive impairment in Lewy body disease

  2020cites this paper
• Dopaminergic Depletion, β‐Amyloid Burden, and Cognition in Lewy Body Disease

  2020cites this paper
• REM sleep behavior disorder in early Parkinson's disease predicts the rapid dopaminergic denervation.

  2020cites this paper
• Longitudinal evolution of non-motor symptoms according to age at onset in early Parkinson's disease.

  2020cites this paper
• Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI.

  2019cites this paper
• NEUROPSYCHOLOGICAL CORRELATES OF STRIATAL DOPAMINERGIC DYSFUNCTION IN PARKINSON’S DISEASE

  2019cites this paper
• Clinical implications of early caudate dysfunction in Parkinson’s disease

  2019influential citation
• Heterogeneous Patterns of Striatal Dopamine Loss in Patients with Young- versus Old-Onset Parkinson’s Disease: Impact on Clinical Features

  2019cites this paper
• Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease.

  2018cites this paper
• Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.

  2018cites this paper
• Can neuroimaging predict dementia in Parkinson’s disease?

  2018cites this paper
• Machine learning identified an Alzheimer’s disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson’s disease dementia

  2018cites this paper
• Consolidation of a Learned Skill Correlates with Dopamine SPECT Uptake in Early Parkinson's Disease

  2018cites this paper
• The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

  2018cites this paper
• Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of 123I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson’s Disease Patients

  2018cites this paper
• Unraveling biomarkers in Parkinson’s disease: the role of Insulin-like growth factor-1 (IGF-1) and DAT imaging

  2018cites this paper
• Distinct Role of Striatal Functional Connectivity and Dopaminergic Loss in Parkinson’s Symptoms

  2017cites this paper
• Distinct brain metabolic patterns separately associated with cognition, motor function, and aging in Parkinson's disease dementia.

  2017cites this paper
• Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers

  2017cites this paper
• Cognitive impairment in progressive supranuclear palsy is associated with tau burden

  2017cites this paper
• 4 Neuropsychological Functions and SPECT Neuroimaging in Parkinson ’ s Disease

  2017cites this paper
• 123 I-FP-CIT SPECT imaging of the dopaminergic state Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques

  2017cites this paper
• Neurotransmission systems in Parkinson’s disease

  2017cites this paper
• Merging Clinical and Imaging Biomarkers to Tackle Parkinson's Disease

  2017cites this paper
• Improvement in Language Function Correlates with Gait Improvement in Drug-naïve Parkinson’s Disease Patients Taking Dopaminergic Medication

  2016cites this paper
• Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD

  2016cites this paper
• Biomarkers for dementia and mild cognitive impairment in Parkinson's disease

  2016cites this paper
• Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD.

  2016cites this paper
• Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study

  2015cites this paper
• Modified Six Elements Test: Earlier diagnosis of the correlation between motor and executive dysfunction in Parkinson's disease without dementia

  2015cites this paper
• The role of prediction and outcomes in adaptive cognitive control.

  2015cites this paper
• Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?

  2015cites this paper
• Multicenter Semiquantitative Evaluation of 123I‐FP‐CIT Brain SPECT

  2015cites this paper
• Heterogeneity of the midbrain dopamine system

  2015influential citation
• Brain 18F-DOPA PET and cognition in de novo Parkinson’s disease

  2015cites this paper
• Caudate dopaminergic denervation and visual hallucinations: evidence from a ¹²³I-FP-CIT SPECT study.

  2014cites this paper
• Prepulse Inhibition is Associated with Attention, Processing Speed, and 123I-FP-CIT SPECT in Parkinson's Disease

  2014cites this paper
• Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease

  2014cites this paper
• Functional imaging in pre-motor Parkinson's disease.

  2014cites this paper
• Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database

  2013cites this paper
• Thalamic Projection Fiber Integrity in de novo

  2013cites this paper
• Anatomical Correlates of Cognitive Functions in Early Parkinson's Disease Patients

  2013cites this paper
• Thalamic Projection Fiber Integrity in de novo Parkinson Disease

  2013cites this paper
• The Heterogeneity of Early Parkinson’s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients

  2013cites this paper
• Nuclear medicine methods in idiopathic Parkinsonism : pre- and postsynaptic dopamine SPECT

  2013cites this paper
• Contributions of the striatum to learning, motivation, and performance: an associative account.

  2012cites this paper
• Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging.

  2012cites this paper
• What predicts cognitive decline in de novo Parkinson's disease?

  2012cites this paper
• 123I-FP-CIT SPECT imaging of the dopaminergic state

  2012cites this paper
• Contributions of the putamen to cognitive function

  2011cites this paper
• Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment

  2011cites this paper
• Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson’s disease

  2011cites this paper
• Neuropsychological Functions and SPECT Neuroimaging in Parkinson’s Disease

  2011cites this paper
• A Précis of Recent Advances in the Neuropsychology of Mild Cognitive Impairment(s) in Parkinson's Disease and a Proposal of Preliminary Research Criteria

  2011cites this paper
• Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD).

  2011cites this paper